{"id":"tp-56013","type":"article-newspaper","title":"Nektar Therapeutics Reports Q3 Net Loss of $55.7 Million","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/56013","datePublished":"2026-11-12T23:01:56.000Z","dateModified":"2026-11-12T23:01:56.000Z","language":"en","abstract":"Revenue declined year over year, while cash and investments in marketable securities totaled $952.9 million at quarter-end.","section":"Business","references":[]}